Irbesartan is an ARB with strong evidence from the IDNT and IRMA-2 trials for nephroprotection in type 2 diabetes. It provides effective 24-hour blood pressure control with once-daily dosing and does not require dose adjustment for renal impairment.
Evidence rating strong. Most-documented uses: effective 24-hour blood pressure reduction, slows progression of diabetic nephropathy (idnt trial), prevents microalbuminuria progression to macroalbuminuria (irma-2). 10 sources indexed (2005–2024), with 2 interaction records on file.
The science
How it works, mechanistically.
Core mechanism
Selectively antagonizes the AT1 receptor, blocking the vasoconstrictor and aldosterone-secreting effects of angiotensin II. Does not inhibit ACE or affect bradykinin metabolism. Provides sustained receptor blockade due to slow dissociation from the AT1 receptor.6
Class
Angiotensin II Receptor Blocker (ARB)
Dosing
Dosing & protocol.
Common range
75–300 mg once daily (as prescribed by your physician)
Recommended form
Oral tablet
Can be taken with or without food; food does not significantly affect bioavailability8
Depletions
What it depletes.
Nutrients this medication can lower over time, and what to replace.
Zinc
Mild
ARB therapy can modestly increase urinary zinc losses in some users, though typically less than ACE inhibitors.
Irbesartan blocks the angiotensin II type 1 receptor, suppressing aldosterone and reducing renal potassium excretion. Combining it with a potassium supplement increases the risk of hyperkalemia, which can cause muscle weakness, paresthesias, and life-threatening arrhythmias. Patients with chronic kidney disease, diabetes, heart failure, or those on NSAIDs are at the highest risk.
Recommendation: Do not take potassium supplements alongside irbesartan unless your prescriber has documented a deficiency and is monitoring you. If combined use is necessary, check serum potassium within 1-2 weeks of starting and at every dose change. Avoid potassium-containing salt substitutes.
Irbesartan blocks the AT1 receptor, reduces sodium reabsorption, and increases lithium retention by the kidney. Multiple published cases with ARBs describe lithium toxicity developing weeks after starting therapy, sometimes at previously well-tolerated lithium doses. Lithium Orotate doses are smaller but use the same renal pathway and the therapeutic window is narrow.
Recommendation: Avoid Lithium Orotate while taking irbesartan. If you must combine them, keep the dose low, stay well hydrated, and ask your prescriber to check serum lithium after 1-2 weeks. Hold the supplement during vomiting, diarrhea, or fever.
Elnaga AAA, Alsaied MA, Elettreby AM et al.. Safety and efficacy of sparsentan versus irbesartan in focal segmental glomerulosclerosis and IgA nephropathy: a systematic review and meta-analysis of randomized controlled trials. BMC nephrology. 2024
Li D, Li B, Peng LX et al.. Therapeutic Efficacy of Piperazine Ferulate Combined With Irbesartan in Diabetic Nephropathy: A Systematic Review and Meta-analysis. Clinical therapeutics. 2020
Palmer AJ, Tucker DM, Valentine WJ et al.. Cost-effectiveness of irbesartan in diabetic nephropathy: a systematic review of published studies. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association. 2005
Zhao J, Tostivint I, Xu L et al.. Efficacy of Combined Abelmoschus manihot and Irbesartan for Reduction of Albuminuria in Patients With Type 2 Diabetes and Diabetic Kidney Disease: A Multicenter Randomized Double-Blind Parallel Controlled Clinical Trial. Diabetes care. 2022
Mullen M, Jin XY, Child A et al.. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Lancet (London, England). 2019
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Irbesartan in NutriStack.
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.